Page 17 - brain-eBook
P. 17

Team Project Name                                  detail, especially those responsible for alcohol-
                                                               related cognitive impairments (Aim 4).
            Repetitive transcranial magnetic stimulation (rTMS)
            for the treatment of alcohol use disorder (AUD): A   This study will contribute to elucidating the
            reverse translational research                     neurophysiological mechanisms of AUD, advancing
                                                               our knowledge of neuromodulation techniques, and
            Research Project                                   eventually the better treatment for AUD patients.
                                                               Together, this study is expected to provide great
            Alcohol use disorder (AUD) is a leading cause of   socio-economic impacts.
            disease burden worldwide and its prevalence in
            Taiwan has been rising for past decades. Although   Key Words
            psychosocial and pharmacological treatments have   Brain  Research  Center  at National  Defense
            been used for the treatment of AUD, the effect is   Medical Center, Alcohol Use Disorder (AUD),
            limited and the relapse rate is high.              Alcohol-related cognitive impairment, Repetitive
            Repetitive  transcranial  magnetic  stimulation    Transcranial Magnetic Stimulation (rTMS),
            (rTMS) offers a promising new way of treatment for   Reverse translational research, Brain imaging,
            AUD. However, the optimal parameters for rTMS      Neuroimaging, Neuroinflammation, Translocator
            treatment and the mechanisms by which rTMS         protein (TSPO), Dopamine, Non-Human Primate
            modulates the neural system are still elusive.     (NHP), Neurophysiology, Cognitive behavior
            To tackle these questions, we propose a            Global Cooperation
            combinatorial approach using a randomized,
            double-blind, sham-controlled clinical trial, together   Provide a platform of NHP models including but
            with multimodal imaging techniques, genetic        not limited to AUD or related disorders for potential
            profiling, electrophysiological recording, cognitive   therapeutic target or drugs
            behavior tests, and the use of non-human primate   The ultimate aim of clinical applications in this
            (NHP) model, to systematically investigate the     project is to optimize the rTMS protocol to attain
            therapeutic potentials of rTMS in the treatment of   effective treatments for individuals with AUD.
            AUD.                                               Compared  to  traditional  research  that  starts
                                                               with basic research in animal models and then
            It is expected through this study, to obtain conclusive   progresses to clinical trials in humans, our reverse-
            evidence for the efficacy of rTMS in the treatment   translational research takes an opposite approach,
            of AUD. The genetic profiling and comprehensive    starting with clinical observations in humans and
            psycho-social interviewing of AUD patients will    then working backward to identify the underlying
            characterize the epidemiology of AUD in Taiwan (Aim   biological mechanisms and better treatment (here,
            1). An imaging biomarker that correlates with the   rTMS) protocols in an NHP model. This approach
            patient’s clinical symptoms can be extremely useful   will allow us to tackle the issue of inconsistent
            for the evaluation of disease severity, progression,   effectiveness and unclear mechanisms in the
            and treatment outcomes (Aim 2).                    clinical use of rTMS in the past.
            On the other hand, the use of NHP model allows     Project Web Page
            us to examine how various stimulation protocols
            of rTMS would differently modulate the neural
            systems (Aim 3), which is not feasible to be done in
            humans. Finally, the development of an NHP model
            of AUD will open the venue for future research to
            study the underlying mechanisms of AUD in further
 16                                                                                                          17
   12   13   14   15   16   17   18   19   20   21   22